NCT02183571View on ClinicalTrials.gov

Bioequivalence Study of Two Strengths of Two Different Metformin Tablets Administered to Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2009

Conditions
Healthy
Interventions
DRUG

Merck Glucophage® high dose

Part I: Treatment A

DRUG

BMS Glucophage® high dose

Part I: Treatment B

DRUG

Merck Glucophage® low dose

Part II: Treatment C

DRUG

BMS Glucophage® low dose

Part II: Treatment D

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY